Description
Tirzepatide Research Peptide
Tirzepatide is a research-grade dual GIP/GLP-1 receptor agonist supplied for controlled laboratory investigation. This 39-amino acid peptide, featuring a C-20 fatty diacid moiety, is studied for its defined interaction with both GIP and GLP-1 receptors. Its precise chemical structure (CAS 2023788-19-2) allows researchers to conduct repeatable studies under standardized conditions, facilitating reproducible data collection in metabolic research models.
Because of its specific agonism at both GIP and GLP-1 receptors, researchers value Tirzepatide for examining dual incretin pathway activation. Studies utilizing this compound emphasize controlled environments to ensure data consistency when observing signaling patterns and interaction behavior. Its well-characterized mechanism provides a robust tool for investigating glucose-dependent insulinotropic signaling and its broader implications in metabolic homeostasis within research models.
In laboratory settings, Tirzepatide is handled following standard peptide preparation and safety procedures. It is supplied as a lyophilized powder. For storage, it should be kept in cool, dry conditions away from direct light. After reconstitution with bacteriostatic water, it is recommended to refrigerate at 2-8°C; for extended storage, freezing at -20°C is appropriate to maintain compound integrity and experimental consistency.
The consistent composition of Tirzepatide reduces experimental variation, offering high compatibility with structured research workflows. This enables researchers to pursue long-term laboratory projects with confidence in the compound’s stable behavior. Its defined characteristics support consistent data generation and interpretation across multiple experimental phases and models.
Ongoing research continues to include Tirzepatide as a key compound for studying complex metabolic pathways. Its defined sequence and stable behavior make it highly suitable for controlled research models investigating incretin-based signaling and its physiological roles.
Important Notice: Tirzepatide 15mg is provided strictly for research use only. This product is not intended for human or animal use, clinical applications, diagnostic procedures, or consumption of any kind. All research must be conducted by qualified professionals in appropriate laboratory environments and in compliance with applicable regulations and guidelines.
Frequently Asked Questions
What is Tirzepatide?
Tirzepatide is a synthetic 39-amino acid peptide classified as a dual GIP/GLP-1 receptor agonist. It is supplied for laboratory research to investigate its mechanism of action involving the activation of both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its structure includes a C-20 fatty diacid moiety, influencing its pharmacokinetic properties in research models.
What is the significance of Tirzepatide’s C-20 fatty diacid moiety in research?
The C-20 fatty diacid moiety on Tirzepatide is a key structural feature designed to influence its interaction with albumin in circulation. In research models, this modification is studied for its potential to extend the compound’s half-life, allowing for sustained receptor activation. This structural characteristic facilitates investigations into prolonged effects on metabolic pathways and receptor dynamics under controlled experimental conditions.
What biological systems are studied using Tirzepatide?
Researchers primarily utilize Tirzepatide to study biological systems involved in metabolic regulation, particularly those linked to glucose homeostasis. This includes investigations into pancreatic islet function, hepatic glucose production, and gastrointestinal hormone signaling. Studies often focus on the interplay between GIP and GLP-1 pathways within controlled in vitro and in vivo models to understand complex metabolic processes.
How does Tirzepatide activate dual incretin pathways?
Tirzepatide functions as an agonist for both the GIP receptor and the GLP-1 receptor. In research settings, it is observed to bind to and activate these receptors, leading to downstream signaling cascades. This dual activation is studied for its potential to modulate glucose-dependent insulin secretion, suppress glucagon release, and affect gastric emptying, providing a comprehensive tool for incretin pathway research.
Why is Tirzepatide of interest in metabolic research?
Tirzepatide is of significant interest in metabolic research due to its unique dual agonism of GIP and GLP-1 receptors. This combined mechanism allows researchers to explore synergistic effects on metabolic parameters that single-receptor agonists may not fully address. Its application in controlled studies contributes to a deeper understanding of incretin biology, glucose regulation, and potential pathways for metabolic intervention.
What are the recommended storage conditions for Tirzepatide?
For optimal stability and research integrity, Tirzepatide should be stored as a lyophilized powder in a cool, dry place, protected from light. After reconstitution with bacteriostatic water, it is recommended to store the solution refrigerated at 2-8°C for short-term use. For extended storage, aliquots should be frozen at -20°C to maintain the compound’s biochemical properties for future experimental applications.
Reviews
There are no reviews yet.